Lou is responsible for developing and strengthening Agilent’s clinical brand and for providing reimbursement expertise across the DGG divisions. Lou brings more than 30 years of commercial and scientific experience in life sciences and molecular diagnostics. Lou joined HP early in his career in US commercial marketing. He held global positions with Agilent in marketing and product management, was a leader in global program management, and led the commercial strategy and launch of Agilent’s array CGH business. Lou co-founded Vela Diagnostics in 2011 and has held leadership roles at Roche Diagnostics and NanoString.
Revolutionary technologies, machines and applications allow NGS to lead scientific advancement and reach the clinic. This momentum has increased in the past year. In this session, we will hear from several large NGS manufacturers and process pipelines about their current goals, upcoming developments and what the future holds for their products.